Los acuerdos previos de compra de vacunas: una contribución fundamental de la economía, la experiencia europea

• Félix LOBO ^[1]
  1. [1] Universidad Carlos III de Madrid

     Universidad Carlos III de Madrid

     Madrid, España

     
• Localización: Papeles de economía española, ISSN 0210-9107, Nº 173, 2022, págs. 179-199
• Idioma: español
• Enlaces
  • Texto completo (pdf)
• Resumen
  • español

    En este artículo estudiamos los acuerdos previos de compra (APC), ampliamente usados en los últimos quince años para incentivar la investigación, desarrollo y fabricación de vacunas y garantizar el suministro, así como su empleo en Europa. Es un mecanismo contractual con el que la economía ha contribuido decisivamente a dar respuesta eficaz a las epidemias del neumococo, ébola y ahora a la pandemia del COVID-19.

    Se discute el contexto innovador e industrial, la naturaleza y características de los APC y el modelo teórico construido por Kremer, Levin y Snyder (2020). También estudia experiencias reales, como la vacuna del neumococo, y, sobre todo, los acuerdos entre la Unión Europea, los Estados miembros y las empresas farmacéuticas, analizando su estrategia, contenido y peculiaridades.

  • English

    In this article we study advance purchase agreements (APA), widely used in the last fifteen years to encourage research, development and manufacturing and to guarantee supply of vaccines. APA are contractual mechanism with which Economics has decisively contributed to providing an effective response to the pneumococcal and Ebola epidemics and now to the COVID 19 pandemic.

    The article discusses the innovative and industrial context, the concept and characteristics of APAs and the theoretical model built by Kremer, Levin and Snyder (February 2020). It also studies real experiences, such as the pneumococcal vaccine and the agreements between pharmaceutical companies and the European Commission and Member States, analyzing strategy, contents and peculiarities

• Referencias bibliográficas
  • ATHEY, S., KREMER, M., SNYDER, C. y TABARROK, A. (2020). In the race for a Coronavirus vaccine, we must go big. Really, really big. New York...
  • BERNDT, E., GLENNERSTER, R., KREMER, M. et al. (2007). Advance market commitments for vaccines against neglected diseases: Estimating costs...
  • BEUC, The European Consumer Organisation (2021). Making the most of EU Advance Purchases of Medicines. BEUC assessment of COVID-19 vaccine...
  • BORGHETTI, J. S., FAIRGRIEVE, D., GOLDBERG, R. et al. (2022). Procurement of COVID-19 vaccines: why were legal liabilities transferred to...
  • BOULET, P., HOEN, E., PEREHUDOFF, K., MARA, K. y TAN, E. (2021). Advanced Purchase Agreements for Covid-19 vaccines: Analysis and comments....
  • CAÑELLES LÓPEZ, M. y JIMÉNEZ SARMIENTO, M. M. (2021). Eficacia y efectos secundarios de las cuatro vacunas aprobadas contra la COVID-19. The...
  • CENTRO EUROPEO DE CONTROL Y PREVENCIÓN DE ENFERMEDADES (European Centre for Disease Prevention and Control, ECDPC) (2022). COVID-19 vaccine...
  • CHALKIDOU, K., TOWSE, A., SILVERMAN, R. et al. (2020). Market-driven, value-based, advanced commitment (MVAC): accelerating the development...
  • COMISIÓN EUROPEA (2020a). Comunicación de la Comisión al Parlamento Europeo, al Consejo Europeo y al Banco Europeo de Inversiones. Estrategia...
  • COMISIÓN EUROPEA (2020b). Factsheet. Coronavirus vaccines strategy. https://ec.europa.eu/commission/presscorner/detail/en/fs_20_1109
  • COMISIÓN EUROPEA (2020c). Coronavirus Commission reaches first agreement on a potential vaccine. 14 de agosto. https://ec.europa.eu/commission/presscorner/detail/en/ip_20_1438
  • COMISIÓN EUROPEA (2021). EU support for vaccines. 18 mayo. https://ec.europa. Eu/info/research-and-innovation/research-area/health-research-and-innovation/coronavirus-research-and-innovation/vaccines_en
  • COMISIÓN EUROPEA (2022a). Questions and answers on COVID-19 vaccination in the EU. https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/safe-covid19-vaccines-europeans/questions-and-answers-covid-19-vaccination-eu_en#negotiations...
  • COMISIÓN EUROPEA (2022b). Safe COVID-19 vaccines for Europeans. https://ec.europa.eu/info/live-work-travel-eu/coronavirus-response/safe-covid19-vaccines-europeans_en
  • COMISIÓN EUROPEA-ASTRAZENECA (2020a). Advance Purchase Agreement («APA») for the production, purchase and supply of a COVID-19 vaccine in...
  • COMISIÓN EUROPEA-ASTRAZENECA (2020b). Advance Purchase Agreement («APA») for the production, purchase and supply of a COVID-19 vaccine in...
  • COMISIÓN EUROPEA-BIONTECH-PFIZER (2020a). Advance Purchase Agreement («APA») for the development, production, priority-purchasing options...
  • COMISIÓN EUROPEA-BIONTECH-PFIZER (2020b). Advance Purchase Agreement («APA») for the development, production, priority-purchasing options...
  • COMISIÓN EUROPEA-CUREVAC (2020). Advance Purchase Agreement («APA») for the development, production, advance purchase and supply of a COVID-19...
  • COMISIÓN EUROPEA-MODERNA (2020). Advance Purchase Agreement («APA») for the production, prioritypurchasing options and supply of a successful...
  • DE BLEEKER-EL GLOBAL (2020). De 1,76 euros (AZ) a 14,8 euros (Moderna): los precios ¿secretos? de las vacunas frente a la COVID. Una ministra...
  • DUKE UNIVERSITY. GLOBAL HEALTH INNOVATION CENTER. LAUNCH AND SCALE SPEEDOMETER (2022). Vaccine purchases. Tracking COVID-19 vaccine purchases...
  • DYER, O. (2021). COVID-19: Countries are learning what others paid for vaccines. BMJ 2021; 372:n281. doi: https://doi.org/10.1136/bmj.n281...
  • THE ECONOMIST EDITORES (2021). What has gone wrong? 3 abril. The Economist, London, Tomo 439, n.º 9239 (Apr 3, 2021): 9. London. https://www.proquest.com/docview/2508064887/fulltextPDF/994407D4CC9449CPQ/5?account...
  • EL PAÍS (2021). Bruselas hace público el contrato con uno de los fabricantes de vacunas. 19 de enero. https://elpais.com/sociedad/2021-01-19/bruselas-hara-publico-el-contrato-con-uno-de-los-fabricantes-de-vacunas.html
  • EUROPEAN MEDICINES AGENCY, EMA (2022a). EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU. 23 de junio. https://www.ema.europa.eu/en/news/ema-recommends-valnevas-covid-19-...
  • EUROPEAN MEDICINES AGENCY, EMA (2022b). EMA 2022-7 COVID-19 vaccines: authorised. Julio. https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/...
  • EUROPEAN MEDICINES AGENCY, EMA (2022c). COVID-19 vaccines: authorised. Actualizado 8 de Agosto.
  • GAVI (2010). Advance Market Commitment for pneumococcal vaccines. Annual report 12 June 2009- 31 March 2010. Prepared by the GAVI Alliance...
  • GAVI (2016). Ebola vaccine purchasing commitment from Gavi to prepare for future outbreaks. https://www.gavi.org/news/media-room/ebola-vaccine-purchasing-commitment-gavi-prepare-future-outbreak
  • GAVI (2021). Advance Market Commitment for pneumococcal vaccines. Annual report 1 January-31 December 2020. Prepared by the AMC Secretariat...
  • GAVI (2022). About our Alliance. https://www.gavi.org/our-alliance
  • GRADUATE INSTITUTE OF INTERNATIONAL AND DEVELOPMENT STUDIES. GLOBAL HEALTH CENTRE (GINEBRA) (2021). COVID-19 Vaccine R&D Investments....
  • GRADUATE INSTITUTE OF INTERNATIONAL AND DEVELOPMENT STUDIES. GLOBAL HEALTH CENTRE (GINEBRA) (2022). COVID-19 Vaccine Access. 14 de febrero....
  • HANNON, E., HANBALI, L., LEHTIMAKI, S. y SCHWALBE, N. (2022). Why we still need a Pandemic Treaty. The Lancet Global Health, 10(9), E1232-E1233,...
  • HOEN, E. y BOULET, P. (2021). The European Commission says COVID-19 vaccines should be global public goods, but do their agreements with pharma...
  • KATELLA, K. (2022). Comparing the COVID-19 vaccines: How are they different? Yalemedicine. 20 de julio. https://www.yalemedicine.org/news/covid-19-vaccine-comparison
  • KREMER, M. (2000a). Creating markets for new vaccines. Part I: Rationale. 2000. Innovation policy and the economy 1: 35-72. NBER. The University...
  • KREMER, M. (2000b). Creating markets for new vaccines. Part II: Design issues. Innovation policy and the economy 1: 73-118. NBER. The University...
  • KREMER, M. y GLENNERSTER, R. (2004). Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases. Princeton, New...
  • KREMER, M., LEVIN, J. D. y SNYDER, C. M. (2020a). Advance market commitments: insights from theory and experience. National Bureau of Economic...
  • KREMER, M., LEVIN, J. D. y SNYDER, C. M. (2020b). Designing advance market commitments for new vaccines. NBER Working Paper Series. National...
  • KYLE, M. (2021). Do patents work? And what else might? Evidence from pharmaceutical innovation. Druid21 Keynote speech. Copenhagen Business...
  • VAN DER LEYEN (2022). Speech by President Von der Leyen at the Vaccine Equity for Africa ceremony, via video message. European Commission....
  • LOBO, F. (2016). Análisis y práctica de las políticas de precios y financiación de los medicamentos. Incluye textos de F. SCOTT MORTON, M....
  • LOBO, F. (2021a). Vacunas para los países en desarrollo: mientras no estemos todos seguros nadie lo estará. El País. 25 de abril. https://elpais.com/sociedad/2021-04-25/vacunas-para-los-paises-en-desarrollo-mientras-no-estemos-todos-seguros-nadie-lo-estara.html
  • LOBO, F. (2021b). Restructuring the global vaccine industry. Research Paper, n.º 134. The South Center. Ginebra. September. 96 p. https://www.southcentre.int/research-paper-134-september2021/#more-16986
  • MÉDICOS SIN FRONTERAS (2020). Analysis and critique of the Advance Market Commitment (AMC) for pneumococcal conjugate vaccines (PCVs) and...
  • MÉDICOS SIN FRONTERAS (2021). Creada la primera reserva mundial de la vacuna contra el ébola. https://www.msf.es/actualidad/suiza/creada-la-primera-reserva-mundial-la-vacuna-ebola
  • MONGE, S., ROJAS-BENEDICTO, A., OLMEDO, C. et al. por IBERCovid 2022. Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2...
  • NEW YORK TIMES (2020). A European official reveals a secret: The U.S. is paying more for Coronavirus vaccines. 18 de diciembre. https://www.nytimes.com/2020/12/18/upshot/coronavirus-vaccines-prices-europe-united-states.html
  • ORGANISATION FOR ECONOMIC CO-OPERATION AND DEVELOPMENT, OECD (2021). Access to COVID-19 vaccines: Global approaches in a global crisis, 11...
  • ORGANIZACIÓN MUNDIAL DE LA SALUD, OMS (2022a). Vaccine Equity. https://www.who.int/campaigns/vaccine-equity. Consultado agosto 2022.
  • ORGANIZACIÓN MUNDIAL DE LA SALUD, OMS (2022b). COVAX pide medidas urgentes para cerrar la brecha en la equidad vacunal. 20 de mayo. https://www.who.int/es/news/item/20-05-2022-covax-calls-for-urgent-action-to-close-vaccine-equity-gap
  • ORGANIZACIÓN MUNDIAL DE LA SALUD, OMS (2022c). COVID-19 vaccine tracker and landscape. 22July2022¬ Novel COVID-19 vaccine tracker. xlsx. 22...
  • ORGANIZACIÓN MUNDIAL DE LA SALUD, OMS (2022d). Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. Julio- WHO Status_COVID_VAX_07July2022.pdf....
  • PEIRÓ, S., GONZÁLEZ LÓPEZ VALCÁRCEl, B. y ORTÚN, V. (2021). ¿Es la solución liberar las patentes de las vacunas COVID? The Conversation. 10...
  • PHARMACEUTICAL TECHNOLOGY EDITORES (2021). COVID19 vaccines advanced purchase agreements tracker: insights on pre-orders and prices. March...
  • SACHS, J. (2021). Propiedad intelectual compartida contra la COVID. Las patentes deben estar al servicio del bien mundial, no la humanidad...
  • SCOTT-MORTON, F. y KYLE, M. (2011). Markets for pharmaceutical products. En MCGUIRE PAULY y P. PITA BARROS. Existe versión española de A....
  • SILVERMAN, R., KRUBINER, C., CHALKIDOU K. y TOWSE, A. (2020). Financing and scaling innovation for the COVID fight: a closer look at demand-side...
  • STIGLITZ, J. E., SPENCE, M. y GHOSH, J. (2021). Nadie estará a salvo mientras no lo estén todos. Resulta urgente la suspensión de los derechos...
  • THORNTON, I., WILSON, P. y GANDHI, G. (2022). «No regrets» purchasing in a pandemic: making the most of advance purchase agreements. Globalization...
  • TOWSE, A. (2020). How should we pay for a COVID-19 Vaccine? OHE. https://www.ohe.org/news/how-should-world-pay-covid-19-vaccine
  • VELÁSQUEZ, G. y SYAM, N. (2021). A new WHO international treaty on pandemic preparedness and response: Can it address the needs of the Global...
  • WATSON, O., BARNSLEY, G., TOOR, J., HOGAN, A. B., WINSKILL, P. y GHANI, A. C. (2022). Global impact of the first year of COVID-19 vaccination:...
  • WOUTERS, O. J., SHADLEN, K. C., SALCHERKONRAD, M., POLLARD, A. J., LARSON, H. J., TEERAWATTANANON, Y. y JIT, M. (2021). Challenges in ensuring...
  • WIKIPEDIA (2022). List of COVID-19 vaccine authorizations. 30 de julio. https://en.wikipedia.org/wiki/List_of_COVID-19_vaccine_authorizations